146 related articles for article (PubMed ID: 24330588)
1. An ongoing case-control study to evaluate the NHS breast screening programme.
Massat NJ; Sasieni PD; Parmar D; Duffy SW
BMC Cancer; 2013 Dec; 13():596. PubMed ID: 24330588
[TBL] [Abstract][Full Text] [Related]
2. An ongoing case-control study to evaluate the NHS Bowel Cancer Screening Programme.
Massat NJ; Sasieni PD; Parmar D; Duffy SW
BMC Cancer; 2014 Dec; 14():945. PubMed ID: 25495609
[TBL] [Abstract][Full Text] [Related]
3. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
[TBL] [Abstract][Full Text] [Related]
4. Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women.
Johns LE; Swerdlow AJ; Moss SM
J Med Screen; 2018 Jun; 25(2):76-81. PubMed ID: 28675954
[TBL] [Abstract][Full Text] [Related]
5. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
Johns LE; Coleman DA; Swerdlow AJ; Moss SM
Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
[TBL] [Abstract][Full Text] [Related]
6. A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England.
Blyuss O; Dibden A; Massat NJ; Parmar D; Cuzick J; Duffy SW; Sasieni P
Cancer Med; 2023 Jan; 12(2):1878-1887. PubMed ID: 35851849
[TBL] [Abstract][Full Text] [Related]
7. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality.
Allgood PC; Warwick J; Warren RM; Day NE; Duffy SW
Br J Cancer; 2008 Jan; 98(1):206-9. PubMed ID: 18059396
[TBL] [Abstract][Full Text] [Related]
8. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
9. Impact of Screening on Breast Cancer Mortality: The UK Program 20 Years On.
Massat NJ; Dibden A; Parmar D; Cuzick J; Sasieni PD; Duffy SW
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):455-62. PubMed ID: 26646362
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the population dose to the UK population from the National Health Service Breast Screening Programme.
Faulkner K; Wallis MG; Neilson F; Whitaker CJ
Radiat Prot Dosimetry; 2008; 129(1-3):184-90. PubMed ID: 18483008
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening; cost-effective in practice?
De Koning HJ
Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
[TBL] [Abstract][Full Text] [Related]
12. Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial.
Allgood PC; Maroni R; Hudson S; Offman J; Turnbull AE; Peacock L; Steel J; Kirby G; Ingram CE; Somers J; Fuller C; Threlfall AG; Gabe R; Maxwell AJ; Patnick J; Duffy SW
Lancet Oncol; 2017 Jul; 18(7):972-980. PubMed ID: 28522311
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
Mukhtar TK; Yeates DR; Goldacre MJ
J R Soc Med; 2013 Jun; 106(6):234-42. PubMed ID: 23761583
[TBL] [Abstract][Full Text] [Related]
14. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Swedish Organised Service Screening Evaluation Group
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
16. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death.
Gabe R; Tryggvadóttir L; Sigfússon BF; Olafsdóttir GH; Sigurdsson K; Duffy SW
Acta Radiol; 2007 Nov; 48(9):948-55. PubMed ID: 18080359
[TBL] [Abstract][Full Text] [Related]
17. Optimal screening mammography reading volumes; evidence from real life in the East Midlands region of the NHS Breast Screening Programme.
Cornford E; Reed J; Murphy A; Bennett R; Evans A
Clin Radiol; 2011 Feb; 66(2):103-7. PubMed ID: 21216324
[TBL] [Abstract][Full Text] [Related]
18. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer.
Moss SM; Summerley ME; Thomas BT; Ellman R; Chamberlain JO
J Epidemiol Community Health; 1992 Aug; 46(4):362-4. PubMed ID: 1431707
[TBL] [Abstract][Full Text] [Related]
19. A case-control study to evaluate the impact of the breast screening programme on mortality in England.
Maroni R; Massat NJ; Parmar D; Dibden A; Cuzick J; Sasieni PD; Duffy SW
Br J Cancer; 2021 Feb; 124(4):736-743. PubMed ID: 33223536
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
